New Pfizer drug opens patients' airways

Pfizer and Boehringer Ingelheim hope to sell a drug called Spiriva in the U.S. to treat chronic obstructive pulmonary disease, known as COPD. The drug may be effective in opening patients' airways, but the FDA says the drug's effect on shortness of breath has not been well documented.

View Full Article in:

Arizona Republic (Phoenix) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC